← SynDRA
JNJ-40411813
SynDRA canonical compound SYN0038096 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GRM2 |
| Mechanism of action | glutamate receptor positive allosteric modulator |
All known targets
Mechanisms of action (all sources)
- GRM2 POSITIVE ALLOSTERIC MODULATOR
- Metabotropic glutamate receptor 2 positive allosteric modulator
- glutamate receptor positive allosteric modulator
Cross-references
Synonyms
- ADX-71149
- 1-butyl-3-chloranyl-4-(4-phenylpiperidin-1-yl)pyridin-2-one
- 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone
- 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-2(1H)-Pyridinone
- 1-butyl-3-chloro-4-(4-phenylpiperidin-1-yl)pyridin-2(1H)-one
- 1-butyl-3-chloro-4-(4-phenylpiperidin-1-yl)pyridin-2-one
- 1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1 'H-[1,4']bipyridinyl-2'-one
- 1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-(1,4')bipyridinyl-2'-one
- 1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4]bipyridinyl-2'-one
- 1'-Butyl-3'-chloro-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-one
- 2(1H)-Pyridinone, 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-
- 612BYT76F3
- A894527
- AC-35478
- ADX71149
- ADX-71149ADX-71149
- BCP23709
- BDBM50051408
- CHEMBL3337527
- CS-3357
- CVB49803
- DB12059
- DTXSID601032323
- EX-A2902
- F85059
- FT-0752754
- GTPL8946
- HY-15748
- HYOGJHCDLQSAHX-UHFFFAOYSA-N
- HZR
- JNJ40411813
- MS-25297
- NCGC00485897-01
- Q27895859
- SB16990
- SCHEMBL1035416
- UNII-612BYT76F3
- RefChem:150542
Look up JNJ-40411813 in the interactive SynDRA portal →